Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.04.2023 | Case report

Mycophenolate-mofetil/prednisolone

Primary cutaneous mucormycosis due to Absidia corymbifera : case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Roche D, et al. Treatment of primary cutaneous mucormycosis due to Absidia corymbiferia in a patient with systemic lupus erythematosus and lupus nephritis. British Journal of Dermatology 185 (Suppl. 1): 30-31 abstr. P12, et al. Jul 2021. Available from: URL: http://doi.org/10.1111/bjd.19978 [abstract] Roche D, et al. Treatment of primary cutaneous mucormycosis due to Absidia corymbiferia in a patient with systemic lupus erythematosus and lupus nephritis. British Journal of Dermatology 185 (Suppl. 1): 30-31 abstr. P12, et al. Jul 2021. Available from: URL: http://​doi.​org/​10.​1111/​bjd.​19978 [abstract]
Metadaten
Titel
Mycophenolate-mofetil/prednisolone
Primary cutaneous mucormycosis due to Absidia corymbifera : case report
Publikationsdatum
01.04.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-37034-2

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Heparin

Case report

Antineoplastics

Case report

Nitrous-oxide

Case report

Paracetamol

Case report

Tamoxifen